Agonist-bound structure of the human P2Y12 receptor.
Agonist-bound structure of the human P2Y12 receptor.
复制标题
人 P2Y(12) 受体激动剂结合结构
DOI:
10.1038/nature13288
复制
发表时间:
2014-05-01
期刊:
影响因子:
64.8
通讯作者:
Zhao, Qiang
中科院分区:
文献类型:
--
作者:
Zhang, Jin;Zhang, Kaihua;Gao, Zhan-Guo;Paoletta, Silvia;Zhang, Dandan;Han, Gye Won;Li, Tingting;Ma, Limin;Zhang, Wenru;Mueller, Christa E.;Yang, Huaiyu;Jiang, Hualiang;Cherezov, Vadim;Katritch, Vsevolod;Jacobson, Kenneth A.;Stevens, Raymond C.;Wu, Beili;Zhao, Qiang
The P2Y12 receptor (P2Y12R), one of eight members of the P2YR family expressed in humans, has been identified as one of the most prominent clinical drug targets for inhibition of platelet aggregation. Consequently, extensive mutagenesis and modeling studies of the P2Y12R have revealed many aspects of agonist/antagonist binding. However, the details of agonist and antagonist recognition and function at the P2Y12R remain poorly understood at the molecular level. Here, we report the structures of the human P2Y12R in complex with a full agonist 2-methylthio-adenosine-5′-diphosphate (2MeSADP, a close analogue of endogenous agonist ADP) at 2.5 Å resolution, and the corresponding ATP derivative 2-methylthio-adenosine-5′-triphosphate (2MeSATP) at 3.1 Å resolution. Analysis of these structures, together with the structure of the P2Y12R with antagonist ethyl 6-(4-((benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283), reveals dramatic conformational changes between nucleotide and non-nucleotide ligand complexes in the extracellular regions, providing the first insight into a different ligand binding landscape in the δ-group of class A G protein-coupled receptors (GPCRs). Agonist and non-nucleotide antagonist adopt different orientations in the P2Y12R, with only partially overlapped binding pockets. The agonist-bound P2Y12R structure answers long-standing ambiguities surrounding P2Y12R-agonist recognition, and reveals interactions with several residues that had not been reported to be involved in agonist binding. As a first example of a GPCR where agonist access to the binding pocket requires large scale rearrangements in the highly malleable extracellular region, the structural studies therefore will provide invaluable insight into the pharmacology and mechanisms of action of agonists and different classes of antagonists for the P2Y12R and potentially for other closely related P2YRs.
登录
查看更多内容
影响因子:
3.6
作者:
Ding, ZG;Kim, S;Kunapuli, SP
通讯作者:
Kunapuli, SP
影响因子:
64.8
作者:
Scheerer, Patrick;Park, Jung Hee;Ernst, Oliver P.
通讯作者:
Ernst, Oliver P.
影响因子:
5.8
作者:
Hoffmann, Kristina;Sixel, Uta;von Kuegelgen, Ivar
通讯作者:
von Kuegelgen, Ivar
影响因子:
14.8
作者:
通讯作者:
--
影响因子:
10.4
作者:
Chang, H.;Yanachkov, I. B.;Frelinger, A. L., III
通讯作者:
Frelinger, A. L., III